StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Wolfe Research Reiterates Outperform Rating on Tenet Healthcare (THC)
October 29, 2024 10:08 AM
Wolfe Research analyst Justin Lake reiterated an Outperform rating and $178.00 price target on Tenet Healthcare (NYSE: THC).The analyst comments ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
Tenet Healthcare (THC) Tops Q3 EPS by 58c; offers guidance
October 29, 2024 6:50 AM
Form 8-K TENET HEALTHCARE CORP For: Oct 29
October 29, 2024 6:46 AM
Tenet Reports Strong Third Quarter 2024 Results; Raises 2024 Financial Outlook
October 29, 2024 6:45 AM
Increasing unusual put option volume: EDR AVTR DECK SKX CPRI EH NWL THC JKS HCA JOBY
October 25, 2024 10:14 AM